Nabriva Therapeutics (NBRV) Short Interest Ratio & Short Volume

Short interest is the volume of Nabriva Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 44,600 shares of NBRV short. 1.50% of Nabriva Therapeutics' shares are currently sold short. Learn More on Nabriva Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NBRV shares currently have a short interest ratio of 4.0. Learn More on Nabriva Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.50% of Nabriva Therapeutics' floating shares are currently sold short.

Nabriva Therapeutics saw a drop in short interest during the month of July. As of July 15th, there was short interest totaling 44,600 shares, a drop of 14.6% from the previous total of 52,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Nabriva Therapeutics currently has issued a total of 32,015,000 shares. Some of Nabriva Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Nabriva Therapeutics currently has a public float of 2,970,000 shares.

1.50% of Nabriva Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Nabriva Therapeutics: Organigram Holdings Inc. (6.79%), DiaMedica Therapeutics Inc. (2.16%), 4D Molecular Therapeutics, Inc. (10.90%), Silence Therapeutics plc (4.18%), Tiziana Life Sciences Ltd (1.26%), INmune Bio, Inc. (40.86%), AC Immune SA (2.33%), Puma Biotechnology, Inc. (7.68%), SELLAS Life Sciences Group, Inc. (12.60%), Janone Inc. (2.44%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($3.75 billion), Charter Communications, Inc. ($3.17 billion), Occidental Petroleum Co. ($2.86 billion), Rivian Automotive, Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.13 billion), Royal Caribbean Cruises Ltd. ($2.05 billion), Palantir Technologies Inc. ($2.04 billion), Extra Space Storage Inc. ($1.98 billion), Enphase Energy, Inc. ($1.66 billion), and Tractor Supply ($1.61 billion). View all of the most shorted stocks.

Short selling NBRV is an investing strategy that aims to generate trading profit from Nabriva Therapeutics as its price is falling. NBRV shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Nabriva Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NBRV, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NBRV, twice per month. The most recent reporting period available is July, 15 2023.